Close Menu

NEW YORK (360Dx) – Quest Diagnostics today announced that it has signed a definitive agreement to acquire the assets of the clinical lab services business of Boyce and Bynum Pathology Laboratories (BBPL).

The relationship between Quest and BBPL, which is based in Columbia, Missouri and serves the Midwest, will result in a broader menu of clinical laboratory and anatomic pathology services throughout the region, according to a Quest statement. The relationship will also give patients access to an expanded network of service centers across the Midwest for greater convenience.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.